aDepartment of Infectious Diseases and Tropical Medicine, Royal Victoria Infirmary
bInflammation, Immunology and Immunotherapy Theme, Institute of Cellular Medicine, Medical School, Newcastle University
cDepartment of Pathology, Royal Victoria Infirmary, Newcastle upon Tyne
dDirector, National Centre for HIV Malignancy, Chelsea & Westminster Hospital, London, UK.
Correspondence to Christopher J.A. Duncan, Institute of Cellular Medicine, Medical School, Newcastle University, Room M3.121 3rd Floor, Leech Building, Newcastle upon Tyne NE2 4HH, UK. Tel: +44 0 191 2082796; e-mail: firstname.lastname@example.org
Received 18 September, 2017
Accepted 20 September, 2017